Factors associated with the development of severe asthma

dc.contributor.authorViinanen, Arja
dc.contributor.authorIlmarinen, Pinja
dc.contributor.authorMehtälä, Juha
dc.contributor.authorJylhävä, Juulia
dc.contributor.authorYlisaukko-oja, Tero
dc.contributor.authorIdänpään-Heikkilä, Juhana J.
dc.contributor.authorKankaanranta, Hannu
dc.contributor.authorLehtimäki, Lauri
dc.contributor.organizationfi=keuhkosairausoppi ja kliininen allergologia|en=Pulmonary Diseases and Clinical Allergology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.92467408925
dc.converis.publication-id491622937
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/491622937
dc.date.accessioned2025-08-28T00:31:56Z
dc.date.available2025-08-28T00:31:56Z
dc.description.abstract<p><strong>Background: </strong>Severe asthma presents a major challenge to health care and negatively affects the quality of life of patients. Understanding the factors predicting the development of severe asthma is limited.</p><p><strong>Objective: </strong>To characterize patients with severe asthma and establish risk factors for the development of severe asthma in a Finnish sample with a nationwide coverage of population, health care, and drug register data.</p><p><strong>Methods: </strong>We used data between January 1, 2014 and December 31, 2020. Pooled data over the years were used to identify characteristics of patients with severe asthma. Annual data were used in machine learning methods and logistic regression to identify factors predicting the development of severe asthma.</p><p><strong>Results: </strong>Analysis of pooled data including 242,164 individuals revealed that patients with severe asthma were more often women, slightly older, multimorbid, and had higher body mass index values compared with patients with nonsevere asthma. They also had higher use of nonasthma-related medications, manifesting as polypharmacy. Annual data from 6908 patients revealed that the most significant predictors of the development of severe asthma were being aged 51 to 60 years (odds ratio [OR] 3.90 [95% CI: 3.42-4.47]), chronic sinusitis (OR 2.48 [95% CI: 2.12-2.89]), and higher blood eosinophil counts (≥600 cells/μL, OR 2.10 [95% CI: 1.56-2.28]). Increases in all medications (nonasthma and asthma medications) were observed in the year before the onset of severe asthma.</p><p><strong>Conclusion: </strong>The results provide a clinically relevant risk factor profile for early identification of the patients at risk of developing severe asthma.</p>
dc.identifier.jour-issn1081-1206
dc.identifier.olddbid205885
dc.identifier.oldhandle10024/188912
dc.identifier.urihttps://www.utupub.fi/handle/11111/35961
dc.identifier.urlhttps://doi.org/10.1016/j.anai.2025.03.002
dc.identifier.urnURN:NBN:fi-fe2025082791077
dc.language.isoen
dc.okm.affiliatedauthorViinanen, Arja
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier BV
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1016/j.anai.2025.03.002
dc.relation.ispartofjournalAnnals of Allergy, Asthma and Immunology
dc.source.identifierhttps://www.utupub.fi/handle/10024/188912
dc.titleFactors associated with the development of severe asthma
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S108112062500119X-main.pdf
Size:
4.07 MB
Format:
Adobe Portable Document Format